These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 12463829)
21. Evaluating the impact and costs of deploying an electronic medical record system to support TB treatment in Peru. Fraser HS; Blaya J; Choi SS; Bonilla C; Jazayeri D AMIA Annu Symp Proc; 2006; 2006():264-8. PubMed ID: 17238344 [TBL] [Abstract][Full Text] [Related]
22. Development of acquired drug resistance in recurrent tuberculosis patients with various previous treatment outcomes. Yoshiyama T; Yanai H; Rhiengtong D; Palittapongarnpim P; Nampaisan O; Supawitkul S; Uthaivorawit W; Mori T Int J Tuberc Lung Dis; 2004 Jan; 8(1):31-8. PubMed ID: 14974743 [TBL] [Abstract][Full Text] [Related]
23. Clofazimine for the treatment of multidrug-resistant tuberculosis: prospective, multicenter, randomized controlled study in China. Tang S; Yao L; Hao X; Liu Y; Zeng L; Liu G; Li M; Li F; Wu M; Zhu Y; Sun H; Gu J; Wang X; Zhang Z Clin Infect Dis; 2015 May; 60(9):1361-7. PubMed ID: 25605283 [TBL] [Abstract][Full Text] [Related]
24. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan. van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387 [TBL] [Abstract][Full Text] [Related]
25. Resistance to first-line tuberculosis drugs in three cities of Nigeria. Lawson L; Yassin MA; Abdurrahman ST; Parry CM; Dacombe R; Sogaolu OM; Ebisike JN; Uzoewulu GN; Lawson LO; Emenyonu N; Ouoha JO; David JS; Davies PD; Cuevas LE Trop Med Int Health; 2011 Aug; 16(8):974-80. PubMed ID: 21564425 [TBL] [Abstract][Full Text] [Related]
26. Are we justified in treating for multidrug-resistant tuberculosis based on positive follow-up smear results? Kumar RS; Kumar AM; Claassens M; Banurekha VV; Sekar G; Venkatesan P; Swaminathan S Int J Tuberc Lung Dis; 2014 Apr; 18(4):449-53. PubMed ID: 24670701 [TBL] [Abstract][Full Text] [Related]
27. Time to initiation of multidrug-resistant tuberculosis treatment and its relation with outcome in a high incidence district in Lima, Peru. Otero L; De Orbegoso A; Navarro AF; Ríos J; Párraga T; Gotuzzo E; Seas C; Van der Stuyft P Trop Med Int Health; 2015 Mar; 20(3):322-5. PubMed ID: 25429916 [TBL] [Abstract][Full Text] [Related]
28. High frequency of multidrug-resistant Mycobacterium tuberculosis isolates in Georgetown, Guyana. Menner N; Günther I; Orawa H; Roth A; Rambajan I; Wagner J; Hahn H; Persaud S; Ignatius R Trop Med Int Health; 2005 Dec; 10(12):1215-8. PubMed ID: 16359400 [TBL] [Abstract][Full Text] [Related]
29. Anti-tuberculosis drug resistance among retreatment patients seen at St Peter Tuberculosis Specialized Hospital. Meskel DW; Abate G; Lakew M; Goshu S; Aseffa A Ethiop Med J; 2008 Jul; 46(3):219-25. PubMed ID: 19271385 [TBL] [Abstract][Full Text] [Related]
30. Implementation of the INNO-LiPA Rif. TB® line-probe assay in rapid detection of multidrug-resistant tuberculosis in Latvia. Skenders GK; Holtz TH; Riekstina V; Leimane V Int J Tuberc Lung Dis; 2011 Nov; 15(11):1546-52, i. PubMed ID: 22008771 [TBL] [Abstract][Full Text] [Related]
31. Identification of drug susceptibility pattern and mycobacterial species in sputum smear positive pulmonary tuberculosis patients with and without HIV co-infection in north west Ethiopia. Mekonen M; Abate E; Aseffa A; Anagaw B; Elias D; Hailu E; Idh J; Moges F; Wolde-Amanuel Y; Asrat D; Yamuah L; Britton S; Stendahl O; Schön T Ethiop Med J; 2010 Jul; 48(3):203-10. PubMed ID: 21073081 [TBL] [Abstract][Full Text] [Related]
32. Early and rapid microscopy-based diagnosis of true treatment failure and MDR-TB. Hamid Salim A; Aung KJ; Hossain MA; Van Deun A Int J Tuberc Lung Dis; 2006 Nov; 10(11):1248-54. PubMed ID: 17131784 [TBL] [Abstract][Full Text] [Related]
33. Influence of previous tuberculosis treatment history on acid-fast bacilli smear and culture conversion. Lee J; Lee BJ; Yoon HI; Lee CT; Lee JH Int J Tuberc Lung Dis; 2012 Oct; 16(10):1344-8. PubMed ID: 23107634 [TBL] [Abstract][Full Text] [Related]
34. Assessment of resistance in multi drug resistant tuberculosis patients. Irfan S; Hassan Q; Hasan R J Pak Med Assoc; 2006 Sep; 56(9):397-400. PubMed ID: 17091751 [TBL] [Abstract][Full Text] [Related]
35. New treatment options for multidrug-resistant tuberculosis. Field SK; Fisher D; Jarand JM; Cowie RL Ther Adv Respir Dis; 2012 Oct; 6(5):255-68. PubMed ID: 22763676 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of the microscopic observation drug susceptibility assay for the rapid detection of MDR-TB and XDR-TB in China: a prospective multicentre study. Huang Z; Qin C; Du J; Luo Q; Wang Y; Zhang W; Zhang X; Xiong G; Chen J; Xu X; Li W; Li J J Antimicrob Chemother; 2015 Feb; 70(2):456-62. PubMed ID: 25266071 [TBL] [Abstract][Full Text] [Related]
37. First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia. Tessema B; Beer J; Emmrich F; Sack U; Rodloff AC Int J Tuberc Lung Dis; 2012 Jun; 16(6):805-11. PubMed ID: 22390880 [TBL] [Abstract][Full Text] [Related]
38. Drug resistance profiles of Mycobacterium tuberculosis isolates: five years' experience and insight into treatment strategies for MDR-TB in Lima, Peru. Timperi R; Han LL; Sloutsky A; Becerra MC; Nardell EA; Salazar JJ; Smith-Fawzi MC Int J Tuberc Lung Dis; 2005 Feb; 9(2):175-80. PubMed ID: 15732737 [TBL] [Abstract][Full Text] [Related]